Home/ Supplements/ Bromelain/ Clinical Enzymes

Clinical Enzymes

product on market Tablet or Pill Natural Clinician Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Clinical Enzymes
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Pancreatin 4X
330 mg
Papain
200 mg
150 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Trypsin
100 mg
Chymotrypsin
3.5 mg
30 mg
Market median: 100.0mg (70 products)
Serratiopeptidase
9 mg
160 mg
Market median: 500.0mg (19 products)
Proprietary Blend
150 mg

Other Ingredients

Enteric Coat with Vegetable Components
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take one tablet, three times daily with 8 oz. of pure water.

Additional Information

PATENT PENDING CLINICAL GRADE FORMULATION

Metadata

Product Details

UPC / SKU0 36733 00805 1
DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID18622
Data Updated2026-04-11
Research

Research Evidence

1
Research Sources
52
Avg Quality
1
Systematic Review
C The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease
Systematic Review VASA. Zeitschrift fur Gefasskrankheiten 2025 PubMed DOI
View all evidence for Bromelain →
Compare

Similar Products

View all Bromelain products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.